August 08, 2022
Oteseconazole is a treatment option for those living with a previously unmet medical need.
August 05, 2022
Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.
August 05, 2022
White House ramps up efforts to fight outbreak.
August 05, 2022
More people getting health coverage, but 26.4 million still don’t have it.